The Landscape of KMT2A-PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome by Adil S.A. Al Hinai, Marta Pratcorona, Tim Grob, François G. Kavelaars, Elena Bussaglia, Mathijs A. Sanders, Josep Nomdedeu, Peter J.M. Valk

Get full text

RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemi... by Mathijs A. Sanders, François G. Kavelaars, Annelieke Zeilemaker, Adil S.A. Al Hinai, Saman Abbas, H. Berna Beverloo, Kirsten van Lom, Peter J.M. Valk

Get full text

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value by Marta Pratcorona, Saman Abbas, Mathijs A. Sanders, Jasper E. Koenders, François G. Kavelaars, Claudia A.J. Erpelinck-Verschueren, Annelieke Zeilemakers, Bob Löwenberg, Peter J.M. Valk

Get full text

Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA by Christian M. Vonk, Emma L. Boertjes, Francois G. Kavelaars, Melissa Rijken, Jolinda M. L. Konijnenburg, Roxanne E. Cromwell, Bob Löwenberg, Tim Grob, Peter J. M. Valk

Get full text

Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging by Martine J. Kallemeijn, François G. Kavelaars, Michèle Y. van der Klift, Ingrid L. M. Wolvers-Tettero, Peter J. M. Valk, Jacques J. M. van Dongen, Anton W. Langerak

Get full text

Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML by Christian M. Vonk, Tim Grob, Melissa Rijken, François G. Kavelaars, Jolinda M. L. Konijnenburg, Gert J. Ossenkoppele, Markus G. Manz, Violaine Havelange, Yngvar Fløisand, Bob Löwenberg, Peter J. M. Valk

Get full text

Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model by Marjolein W. J. Wentink, Tomas Kalina, Martin Perez-Andres, Lucia del Pino Molina, Hanna IJspeert, François G. Kavelaars, Arjan C. Lankester, Quentin Lecrevisse, Jacques J. M. van Dongen, Alberto Orfao, Mirjam van der Burg, Mirjam van der Burg

Get full text

High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML) by Mihada Bajrami Saipi, Alessia Ruiba, Marcus Matthias Schittenhelm, Gunnar Blumenstock, Balázs Győrffy, Serena Fazio, Marlon Hafner, Anna-Lena Ahrens, Lara Aldinger, Vanessa Aellig, François G. Kavelaars, César Nombela-Arrieta, Falko Fend, Peter J. M. Valk, Driessen Christoph, Kerstin Maria Kampa-Schittenhelm

Get full text

Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome by Julia C. Obenauer, François G. Kavelaars, Mathijs A. Sanders, Remco M. Hoogenboezem, Andrica C. H. de Vries, Paulina M. H. van Strien, Valerie de Haas, Franco Locatelli, Henrik Hasle, Peter J. M. Valk, Ivo P. Touw, Marry M. van den Heuvel-Eibrink

Get full text

Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations by Saman Abbas, Mathijs A. Sanders, Annelieke Zeilemaker, Wendy M.C. Geertsma-Kleinekoort, Jasper E. Koenders, Francois G. Kavelaars, Zabiollah G. Abbas, Souad Mahamoud, Isabel W.T. Chu, Remco Hoogenboezem, Justine K. Peeters, Ellen van Drunen, Janneke van Galen, H. Berna Beverloo, Bob Löwenberg, Peter J.M. Valk

Get full text